Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 199-204

  Cassinotti, P ^a   Siegl, G ^a   Michel, B A ^b   Bruhlmann P ^b  

^a Inst Clin Microbiol and Immunol   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Diagnosis; PCR; Persistence; Polymerase chain reaction; Synovial fluid

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; BONE MARROW BIOPSY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; SYNOVIAL FLUID;

ADULT; ANTIBODIES, VIRAL; ARTHRITIS, INFECTIOUS; BONE MARROW; DNA, VIRAL; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

DNA VIRUSES; PARVOVIRUS;

EID: 0031670475     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<199::AID-JMV4>3.0.CO;2-2     Document Type: Article

References (26)

1. Ager EA, Chin TD, Poland JD (1966): Epidemic erythema infectiosum. New England Journal of Medicine 275:1326-1331.
2. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CLR, Cohen BJ, Mortimer PP, Pereira MS (1983): Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet ii:1378.
3. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos M (1991): Genital human papillomavirus infection in female university students as determined by a PCR-based method. Journal of the American Medical Association 265: 472-477.
4. Branigan PJ, Gerard HC, Hudson AP, Schumacher HR (1996): Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis and Rheumatism 39:1740-1746.
5. Cassinotti P (1995): Human parvovirus B19 infections and their diagnosis. Alpe Adria Microbiology Journal 4:235-246.
6. Cassinotti P, Weitz M, Siegl G (1993): Human parvovirus-B19 infections: Routine diagnosis by a new nested polymerase chain reaction assay. Journal of Medical Virology 40:228-234.
7. Cassinotti P, Bas S, Siegl G, Vischer TL (1995): Association between human parvovirus B19 infection and arthritis. Annals of the Rheumatic Diseases 54:498-500.
8. Cassinotti P, Burtonboy G, Fopp M, Siegl G (1997): Evidence for persistence of human parvovirus B19 DNA in bone marrow. Journal of Medical Virology 53:229-232.
9. Coulombel L, Morinet F, Mielot F, Tchernia G (1989): Parvovirus infection, leukaemia, and immunodeficiency. Lancet 1:101-102.
10. Dijkmans BAC, van Elsacker-Niele AMV, Salimans MMM, van Albada-Kuipers GA, De Vries E, Weiland HT (1988): Human parvovirus B19 DNA in synovial fluid. Arthritis and Rheumatism 31: 279-281.
11. Faden H, Gary GW, Anderson LJ (1992): Chronic parvovirus infection in a presumably immunologically healthy woman. Clinical Infectious Diseases 15:595-597.
12. Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ (1993): Parvovirus B19 specific DNA in bone marrow from B19 arthropathy patients: Evidence for B19 virus persistence. Journal of Infectious Diseases 167:744-748.
13. Jawad ASM (1993): Persistent arthritis after human parvovirus B19 infection. Lancet 341:494.
14. Kandolf R, Kirschner P, Hofschneider PH, Vischer TL (1989): Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization. Clinical Rheumatology 8:398-401.
15. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott JRM, Mollan RAB (1995a): A study of the role of parvovirus B19 in rheumatoid arthritis. British Journal of Rheumatology 34:809-813.
16. Kerr JR, Curran MD, Moore JE, Coyle PV, Ferguson WP (1995b): Persistent parvovirus B19 infection. Lancet 345:1118.
17. Miki NPH, Chantler JK (1992): Non-permisiveness of synovial membrane cells to human parvovirus B19 in vitro. Journal of General Virology 73:1559-1562.
18. Nikkari S, Luukkainen R, Mötiönen T, Meurman O, Hannonen P, Skurnik M, Toivanen P (1994): Does parvovirus B19 have a role in rheumatoid arthritis? Annals of the Rheumatic Diseases 53:106-111.
19. Nikkari S, Roivainen A, Hannonen P, Möttönen T, Luukkainen R, Yli-Jama T, Toivanen P (1995): Persistence of parvovirus B19 in synovial fluid and bone marrow. Annals of the Rheumatic Diseases 54:597-600.
20. Nocton JJ, Miller LC, Tucker LB, Schaller JG (1993): Human parvovirus B19-associated arthritis in children. Journal of Pediatrics 122:186-190.
21. Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ (1985): Human parvovirus-associated arthritis: A clinical and laboratory description. Lancet ii:422-425.
22. Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K, Abe K (1995): Persistent infection of human parvovirus B19 in a normal subject. Lancet 346:851.
23. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR (1986): Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal of Virology 58:921-936.
24. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K (1997): Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349:1063-1065.
25. White DG, Mortimer PP, Blake DR, Woolf AD, Cohen BJ, Bacon PA (1985): Human parvovirus arthropathy. Lancet i:419-21.
26. Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, Caul O, Dieppe PA (1989): Clinical manifestations of human parvovirus B19 in adults. Archives of Internal Medicine 149:1153-1156.